Compare MRUS & BDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
Belden designs, manufactures, and markets advanced networking, connectivity, and cable solutions for industrial automation, smart buildings, and broadcast markets. Their portfolio includes cables, connectors, and networking equipment, enabling secure, reliable data transmission for applications in data centers, healthcare, education, hospitality, and more.